Mercado cerrado -
Otros sitios de cotización
|
Varia. Cinco días. | Varia. 1 de enero. | ||
0,06 AUD | -11,76 % | -6,25 % | -15,49 % |
Resumen de negocios
Directores
Directores | Puesto | Edad | Desde |
---|---|---|---|
Gisela Mautner
CEO | Chief Executive Officer | - | - |
Director of Finance/CFO | - | 01/03/19 | |
Olivier Laczka
CTO | Chief Tech/Sci/R&D Officer | - | 16/10/19 |
Jeanette Bell
COO | Chief Operating Officer | - | 23/04/19 |
John Wilkinson
CTO | Chief Tech/Sci/R&D Officer | - | 01/02/18 |
Gregory Ambra
PRN | Corporate Officer/Principal | - | 16/10/19 |
Ron Sinani
LAW | General Counsel | - | 01/01/17 |
Alexander Hunter
PRN | Corporate Officer/Principal | - | 06/11/19 |
David Franks
SEC | Corporate Secretary | 53 | 16/01/17 |
Administradores
Administradores | Puesto | Edad | Desde |
---|---|---|---|
Fred Bart
CHM | Chairman | 69 | 08/05/20 |
Peter Marks
BRD | Director/Board Member | 68 | 15/03/16 |
Boris Patkin
BRD | Director/Board Member | - | 26/03/20 |
Gisela Mautner
CEO | Chief Executive Officer | - | - |
Clase de acciones
Vote | Quantity | Flotante | Autocontrol | Total Float | |
---|---|---|---|---|---|
Acción A | 1 | 292 237 950 | 189 349 920 ( 64,79 %) | 0 | 64,79 % |
Información de la empresa
Varia. 1 de ene. | Capi. | |
---|---|---|
-15,49 % | 12,91 M | |
-3,93 % | 86,16 mil M | |
+2,76 % | 40,17 mil M | |
-17,32 % | 31,47 mil M | |
+54,44 % | 25,24 mil M | |
-12,64 % | 15,82 mil M | |
-9,12 % | 11,96 mil M | |
-15,43 % | 11,89 mil M | |
-42,56 % | 11,61 mil M | |
+4,87 % | 8840,56 M |
- Bolsa de valores
- Acciones
- Acción NOX
- Empresa Noxopharm Limited